BMS1P13

Across TCGA pan-cancer cohorts, BMS1P13 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated BMS1P13 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher BMS1P13 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated BMS1P13 expression acts as an unfavorable survival marker, although some lineages such as SKCM and OV show a favorable association.

KICH, LIHC, and KIRC are the cancer types where BMS1P13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.374	0.921	<.001	105	view →
LIHC	OS	Tertile	All	0.526	0.793	<.001	90	view →
KIRC	DFS	Tertile	All	0.507	0.821	<.001	60	view →
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	45	view →
SKCM	DFS	Tertile	All	0.320	0.190	.013	30	view →
MESO	DFS	Tertile	III,IV	0.172	0.394	.007	27	view →
THCA	DFS	Tertile	IV	0.473	0.965	<.001	24	view →
ACC	OS	Tertile	IV	0.327	0.633	.045	18	view →
OV	OS	Tertile	IV	0.972	0.700	.034	6	view →
LGG	DFS	Tertile	All	0.220	0.453	.035	3	view →
STAD	OS	Quartile	IV	0.174	0.454	.022	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

BMS1P13–KICH (DFS)

Open the KICH breakdown →